Reliable Diagnostics for Professionals
Contact usReagena is a Finnish, diagnostics growth company with product development and manufacturing facility in Kuopio region. Reagena’s mission is to be partner of choice in providing solutions and services that optimize patient care pathways while reducing the burden on healthcare.
Explore Our Zoonotic Solutions
Reagena is an undisputed leader in Hantavirus rapid diagnostics. Reagena offers rapid tests intended for qualitative detection for Puumala virus and Dobrava or Hantaan virus specific IgM antibodies from human serum or plasma. Test results are used as an aid in the diagnosis of acute Hantavirus infections.


Reagena is a pioneer in rapid diagnostics for zoonotic diseases and lately focused on the diagnostic tests for Lyme Borreliosis, Lyme neuroborreliosis and Tick-borne encephalitis. These tests are intended for use as an aid for diagnosis of Lyme Disease and Tick-borne encephalitis.
News
News
Reagena test efficiently detects Hantavirus
The Navarrete study that the Reagena POC Puumala IgM test efficiently detects Hantavirus Andes virus infections.
News
ESCMID Global 2026, Munich
Reagena is participating in ESCMID (Congress of the European Society ofClinical Microbiology and Infectious Diseases). Come and meet us at our…
News
Medica 2025
Reagena is attending Medica 2025. From 17 to 20 November 2025, MEDICA will once again gather international experts from the medical industry in…
News
Mika Laava to strengthen new mobile product group
Mika Laava, a graduate engineer, has joined Reagena’s Product Development and Quality organization as of April 1, 2025, as a product development…